Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1901 1
1904 1
1905 2
1906 1
1908 2
1912 1
1915 2
1916 1
1918 1
1930 3
1946 1
1949 5
1950 4
1951 6
1952 1
1954 2
1955 6
1956 3
1957 5
1958 1
1959 2
1960 1
1964 4
1965 1
1966 1
1967 3
1968 2
1969 2
1970 5
1971 2
1972 8
1973 3
1974 7
1975 5
1976 13
1977 9
1978 6
1979 5
1980 4
1981 19
1982 11
1983 12
1984 13
1985 20
1986 22
1987 24
1988 17
1989 15
1990 24
1991 15
1992 15
1993 30
1994 21
1995 25
1996 24
1997 23
1998 23
1999 15
2000 15
2001 19
2002 25
2003 34
2004 30
2005 40
2006 37
2007 54
2008 33
2009 36
2010 51
2011 51
2012 55
2013 57
2014 61
2015 46
2016 55
2017 59
2018 64
2019 49
2020 54
2021 64
2022 52
2023 60
2024 61
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,526 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacoepidemiology.
Moore N, Blin P, Droz C. Moore N, et al. Handb Exp Pharmacol. 2019;260:433-451. doi: 10.1007/164_2019_318. Handb Exp Pharmacol. 2019. PMID: 31768750 Review.
Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données.
Berdaï D, Thomas-Delecourt F, Szwarcensztein K; table ronde « recherche clinique et méthodologie » des Ateliers de Giens XXXIII; d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F. Berdaï D, et al. Among authors: moore n. Therapie. 2018 Feb;73(1):1-12. doi: 10.1016/j.therap.2017.12.001. Epub 2017 Dec 12. Therapie. 2018. PMID: 29499906 French. No abstract available.
Maturation of germinal center B cells after influenza virus vaccination in humans.
McIntire KM, Meng H, Lin TH, Kim W, Moore NE, Han J, McMahon M, Wang M, Malladi SK, Mohammed BM, Zhou JQ, Schmitz AJ, Hoehn KB, Carreño JM, Yellin T, Suessen T, Middleton WD, Teefey SA, Presti RM, Krammer F, Turner JS, Ward AB, Wilson IA, Kleinstein SH, Ellebedy AH. McIntire KM, et al. Among authors: moore ne. J Exp Med. 2024 Aug 5;221(8):e20240668. doi: 10.1084/jem.20240668. Epub 2024 Jun 27. J Exp Med. 2024. PMID: 38935072
Pharmacovigilance - The next chapter.
Moore N, Berdaï D, Blin P, Droz C. Moore N, et al. Therapie. 2019 Dec;74(6):557-567. doi: 10.1016/j.therap.2019.09.004. Epub 2019 Oct 1. Therapie. 2019. PMID: 31623850 Review.
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
Lapeyre-Mestre M, Sapède C, Moore N; les participants à la table ronde N° 5 de Giens XXVIII :; Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C. Lapeyre-Mestre M, et al. Among authors: moore n. Therapie. 2013 Jul-Aug;68(4):241-6. doi: 10.2515/therapie/2013037. Therapie. 2013. PMID: 27392726 French. No abstract available.
New oral anticoagulants (NOAC) and liver injury.
Moore N, Blin P, Gulmez SE. Moore N, et al. J Hepatol. 2014 Aug;61(2):198-9. doi: 10.1016/j.jhep.2014.05.010. Epub 2014 May 15. J Hepatol. 2014. PMID: 24837361 Free article. No abstract available.
1,526 results